Workflow
化学制品
icon
Search documents
达威股份: 募集资金管理制度
Zheng Quan Zhi Xing· 2025-07-08 11:18
四川达威科技股份有限公司 (以下简称"《创业板上市公司规范运作指引》")、 《深圳 证券交易所上市公司募集资金管理办法》、 第一章 总则 第一条 为规范四川达威科技股份有限公司(以下简称"公司")对募集资 金的使用和管理,提高募集资金的使用效率和效益,维护公司、股东及债权人的 合法权益,特制定本制度。 第二条 本制度是根据《中华人民共和国公司法》 (以下简称"《公司法》")、 《中华人民共和国证券法》(以下简称"《证券法》")、中国证券监督管理委员会 (以下简称"证监会")、《上市公司证券发行管理办法》、《深圳证券交易所创业 板股票上市规则》(以下简称 "《创业板上市规则》")、《深圳证券交易所创业板 上市公司规范运作指引》 (以下简称"《公司章程》")等规定,结合公司实际情况 制定的。 《创业板信息披露业务备忘录第 1 号— —超募资金使用》等有关法律、行政法规、部门规章、规范性文件及《四川达威 科技股份有限公司章程》 第三条 本制度所指"募集资金"是指公司通过公开发行证券(包括首次公 开发行股票、配股、增发、发行可转换公司债券、分离交易的可转换公司债券、 权证等)以及非公开发行证券向投资者募集并用于特定用 ...
达威股份: 关联交易管理办法
Zheng Quan Zhi Xing· 2025-07-08 11:18
四川达威科技股份有限公司 第一章 总则 第一条 为进一步加强对公司关联交易的管理,提高公司规范运作水平,保 证公司关联交易的公允性,维护公司及公司全体股东的合法权益,根据《中华人 民共和国公司法》、 《中华人民共和国证券法》、 《深圳证券交易所创业板股票上市 规则》及《四川达威科技股份有限公司章程》的规定,特制定本办法。 第二条 公司与关联人之间的关联交易应签订书面协议。协议的签订应当遵 循平等、自愿、等价、有偿的原则,协议内容应明确、具体。公司应将该协议的 订立、变更、终止及履行情况等事项按照有关规定予以披露。 公司的关联交易应当遵循以下基本原则: (一)符合诚实信用的原则; (二)符合公开、公平、公允、平等、自愿、等价、有偿原则; (三)公司董事会应当根据客观标准判断该关联交易是否对公司有利,必要 时应当聘请专业评估师或独立财务顾问。 第三条 关联交易活动应遵循公正、公平、公开的原则,关联交易的价格原 则上不能偏离市场独立第三方的价格或收费的标准。公司应对关联交易的定价依 据予以充分披露。 第二章 关联人及关联交易认定 第四条 公司的关联人包括关联法人和关联自然人。 第五条 公司的关联法人是指: (一)直 ...
达威股份: 股东会议事规则
Zheng Quan Zhi Xing· 2025-07-08 11:18
Core Points - The document outlines the rules and regulations governing the shareholders' meetings of Sichuan Dawi Technology Co., Ltd, ensuring compliance with relevant laws and protecting shareholders' rights [1][2][3] Group 1: Shareholders' Meeting Authority - The shareholders' meeting is the company's authority body, responsible for decisions on mergers, acquisitions, amendments to the articles of association, and significant asset transactions exceeding 30% of the company's total assets [1][2][3] - Specific transactions, such as those involving related parties exceeding 30 million RMB or 5% of the latest audited net assets, must be approved by the shareholders' meeting [1][2][3] Group 2: Transaction Standards - Transactions that exceed 50% of the company's latest audited total assets or involve significant income or profit thresholds must be submitted for shareholders' approval [2][3][4] - The document specifies various types of transactions, including asset purchases, external investments, and financial assistance, that require shareholder review if they meet certain criteria [3][4][5] Group 3: Meeting Procedures - The company must hold an annual shareholders' meeting within six months after the end of the previous fiscal year, with provisions for calling temporary meetings under specific circumstances [9][10][11] - Shareholders holding more than 10% of the company's shares can request a temporary meeting, and the board must respond within ten days [11][12] Group 4: Voting and Decision-Making - Decisions at the shareholders' meeting require a majority or two-thirds majority vote, depending on whether the resolution is ordinary or special [27][28][30] - The document outlines the voting process, including the requirement for independent directors to report on their duties and the need for transparency in voting results [20][21][27] Group 5: Disclosure and Reporting - The company must disclose relevant financial reports and evaluations for transactions requiring shareholder approval, ensuring transparency and compliance with regulations [5][6][7] - Meeting records must be maintained for at least ten years, documenting attendance, proposals, and voting outcomes [29][30]
宏柏新材: 北京市中伦律师事务所关于江西宏柏新材料股份有限公司2025年第二次临时股东大会的法律意见书
Zheng Quan Zhi Xing· 2025-07-08 11:15
Group 1 - The legal opinion letter was issued by Beijing Zhonglun Law Firm regarding Jiangxi Hongbai New Materials Co., Ltd. for the 2025 second extraordinary general meeting of shareholders [1][2] - The law firm confirmed that the company provided all necessary documents and materials for the issuance of the legal opinion letter, ensuring their authenticity and completeness [2] - The meeting was convened and conducted in accordance with the Company Law, Shareholders' Meeting Rules, and the company's articles of association [2][6] Group 2 - The notice for the shareholders' meeting included details such as time, location, meeting format, attendees, and registration methods, complying with the requirements of the Shareholders' Meeting Rules [2] - A total of 7 shareholders attended the meeting in person, representing 258,735,908 shares, which accounted for 41.1118% of the total voting shares [3] - An additional 280 shareholders participated via online voting, representing 3,859,559 shares, or 0.6133% of the total voting shares [3] Group 3 - There were no temporary proposals submitted by shareholders for this meeting [4] - The voting process was conducted according to the Company Law and the company's articles of association, with results announced immediately after the voting [4][5] - All resolutions presented at the meeting were passed with valid votes, confirming the legality of the voting procedures and results [5][6] Group 4 - The law firm concluded that the convening, conducting, and voting procedures of the 2025 second extraordinary general meeting of shareholders were in compliance with relevant laws and regulations [6] - The qualifications of the convenor and attendees were deemed valid, ensuring the legitimacy of the meeting [6]
东材科技: 四川东材科技集团股份有限公司股票交易异常波动公告
Zheng Quan Zhi Xing· 2025-07-08 11:15
证券代码:601208 证券简称:东材科技 公告编号:2025-055 转债代码:113064 转债简称:东材转债 重要风险提示: ? 四川东材科技集团股份有限公司(以下简称"公司"或"本公司")股票 于 2025 年 7 月 4 日、7 月 7 日、7 月 8 日连续三个交易日内日收盘价格涨幅偏离 值累计超过 20%。根据《上海证券交易所交易规则》的有关规定,属于股票交易 异常波动的情形。 ? 经公司自查核实,并向控股股东、实际控制人发函查证,截至本公告披 露日,均不存在应披露而未披露的重大信息。 ? 根据中证指数有限公司发布的相关数据,截至 2025 年 7 月 7 日,本公司 的静态市盈率为 53.90、市净率为 2.10,所属化学原料及化学制品制造业的静态 市盈率为 24.31、市净率为 1.96,公司的市盈率和市净率水平均高于行业平均水 平。敬请广大投资者注意二级市场交易风险,理性投资。 一、股票交易异常波动的具体情况 四川东材科技集团股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实、准确和完整承担个别及连带责任。 (四 ...
凯龙股份: 2025年半年度业绩预告
Zheng Quan Zhi Xing· 2025-07-08 11:15
Group 1 - The company expects to achieve a net profit of 100 million to 120 million yuan for the period from January 1, 2025, to June 30, 2025, indicating a significant increase of 53.64% to 84.37% compared to the same period last year, where the net profit was 65.0865 million yuan [1] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 90 million and 110 million yuan, representing a growth of 90.56% to 132.90% compared to the previous year's figure of 47.2299 million yuan [1] - The basic earnings per share are anticipated to be between 0.20 yuan and 0.24 yuan, compared to 0.14 yuan per share in the same period last year [1] Group 2 - The significant increase in net profit is attributed to a rise in revenue and a decrease in blasting service costs, which has further enhanced the company's profit level [1] - The performance forecast has not been audited by a registered accountant and is based on preliminary calculations by the company's finance department [1] - Investors are advised to make cautious decisions based on the preliminary nature of the forecast, with the final data to be disclosed in the 2025 semi-annual report [1]
盐湖股份: 关于实际控制人增持公司股份计划实施进展暨增持时间过半的公告
Zheng Quan Zhi Xing· 2025-07-08 10:18
青海盐湖工业股份有限公司 关于实际控制人增持公司股份计划实施进展暨增持时间过 一、增持计划的基本情况 基于对公司未来持续稳定发展的信心和长期投资价值的认可,为增强投资者 信心,公司实际控制人中国五矿计划自 2025 年 4 月 9 日起 6 个月内,通过深圳 证券交易所系统允许的方式(包括但不限于大宗交易和集中竞价交易)增持公司 A 股股票。本次计划增持股份总数量不少于 21,166.29 万股。具体内容详见公司 于 2025 年 4 月 9 日披露的《关于实际控制人增持计划的公告》 证券代码:000792 证券简称:盐湖股份 公告编号:2025-037 半的公告 公司实际控制人中国五矿集团有限公司保证向本公司提供的信息内容真实、 准确、完整,没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 青海盐湖工业股份有限公司(以下简称"公司")近日收到实际控制人中国 五矿集团有限公司(以下简称"中国五矿")出具的《关于增持公司股份计划实 施进展暨增持时间过半的告知函》,现将相关情况公告如下: 《深圳证券交易所股票上市规则》 《深圳证券交易所上市公司自律监管指引 ...
业绩遭遇过山车,海湾化学主动撤回IPO申请
Qi Lu Wan Bao Wang· 2025-07-08 10:13
Core Viewpoint - The IPO application of Qingdao Gulf Chemical Co., Ltd. has been officially terminated by the Shanghai Stock Exchange after a prolonged waiting period of 19 months without a response to inquiries, marking the end of a two-and-a-half-year listing journey [1] Group 1: IPO Process and Challenges - Gulf Chemical submitted its application for the Shanghai Stock Exchange main board on December 28, 2022, aiming to raise 3 billion yuan by issuing 253 million new shares for projects including epoxy resin and epoxy chloropropane [4] - The company faced significant hurdles, including being placed on the inspection list shortly after submitting its prospectus and entering a 19-month silence after receiving the first round of inquiries [4][6] - A regulatory warning from the exchange highlighted two major violations: "false解除" of equity pledges and multiple inaccuracies in financial accounting, which affected the assessment of the company's eligibility for listing [4][6] Group 2: Financial Performance and Market Conditions - From 2019 to mid-2022, Gulf Chemical's net profit excluding non-recurring items surged from 425 million yuan to 2.04 billion yuan, but profitability was severely squeezed in the second half of 2022 due to falling product prices and high raw material costs [6] - The company distributed over 3 billion yuan in cash dividends from 2019 to mid-2022, including over 1.5 billion yuan just before the IPO, raising questions about its fundraising plans [6] Group 3: Future Outlook and Company Governance - Despite the failed IPO, this situation provides Gulf Chemical an opportunity to reassess and strengthen its internal governance and operational resilience [7] - The company is expected to address the regulatory issues raised and improve its financial disclosure and profitability to better position itself for future market opportunities [7]
福莱新材: 福莱新材关于归还用于暂时补充流动资金的闲置募集资金的公告
Zheng Quan Zhi Xing· 2025-07-08 09:13
浙江福莱新材料股份有限公司(以下简称"公司")于 2024 年 7 月 10 日召 开第三届董事会第三次会议和第三届监事会第三次会议,审议通过了《关于使用 部分闲置募集资金暂时补充流动资金的议案》,同意公司使用不超过人民币 1 亿 元闲置募集资金暂时补充流动资金,在保证募集资金投资项目正常实施的前提下, 使用期限自董事会审议通过之日起不超过 12 个月。保荐人对此事项出具了无异 议的专项核查意见。具体内容详见公司于 2024 年 7 月 11 日披露于上海证券交易 所网站(www.sse.com.cn)及指定信息披露媒体的《福莱新材关于使用部分闲置 募集资金暂时补充流动资金的公告》(公告编号:临 2024-091)。 证券代码:605488 证券简称:福莱新材 公告编号:临 2025-092 债券代码:111012 债券简称:福新转债 浙江福莱新材料股份有限公司 关于归还用于暂时补充流动资金的闲置募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 公司在上述有效期限内实际使用闲置募集资金暂时补充流动资金的金额为 人 ...
新开源收盘上涨1.08%,滚动市盈率26.55倍,总市值81.95亿元
Sou Hu Cai Jing· 2025-07-08 09:12
来源:金融界 博爱新开源医疗科技集团股份有限公司的主营业务是精细化工和精准医疗。公司的主要产品是 PVPK30、PVP-I、PVP系列其他、欧瑞姿系列、肿瘤早期诊断、分子诊断服务、基因检测技术服务、精 准医疗服务。 最新一期业绩显示,2025年一季报,公司实现营业收入3.25亿元,同比-17.69%;净利润8042.03万元, 同比-33.75%,销售毛利率44.07%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13新开源26.5523.442.2081.95亿行业平均 47.1253.433.8581.04亿行业中值40.9742.142.5244.03亿1正丹股份8.1410.403.88123.74亿2星湖科技 10.2212.631.42119.13亿3梅花生物10.3811.392.02312.10亿4嘉化能源11.2812.011.17121.03亿5聚合顺 11.4811.881.8535.69亿6万华化学14.5213.321.771736.28亿7雪峰科技14.9713.631.8391.09亿8浙江龙盛 15.1116.580.97336.72亿9宇新股份16.3914.36 ...